InvestorsHub Logo
Followers 45
Posts 1684
Boards Moderated 0
Alias Born 11/28/2018

Re: None

Tuesday, 02/23/2021 1:03:36 PM

Tuesday, February 23, 2021 1:03:36 PM

Post# of 233055
I have relayed and parlayed all relative information to contacts well established in medical field from major hospitals and my contacts formerly with BP and with this information, they have given me major assurances that the PR and path forward with FDA is about secondary endpoints that are being looked at. The probability is extremely high that discussion are related to EUA being granted for the secondary endpoints being hit and the format to which Virologix will be used to treat either Severe or Critical patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News